Deficits in plasma oestradiol measurement in studies and management of breast cancerMitch Dowsett(Royal Marsden NHS Foundation Trust), Elizabeth Folkerd(Royal Marsden Hospital)Breast Cancer ResearchFebruary 1, 200410.1186/bcr960Cited by 82SaveCiteExport RISWatch citationsRelated PapersEffectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo|Breast Cancer Research|2012|33